Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
D000293:Adolescent; D000328:Adult; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010592:Pharmaceutic Aids; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*
D009539:Nicotinic Acids; D010592:Pharmaceutic Aids; D010919:Placebos; D009536:Niacinamide; D002746:Chlorpromazine